| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |